| Program | Indication | Mechanism of Action | Stage | Partner |
|---|---|---|---|---|
| AFC-5128 | Neuropathic Pain Multiple Sclerosis |
Oral CNS-Penetrant P2X7 Antagonist | Preclinical | |
| P2X7 Compounds | Neurodegenerative Diseases | Oral Compounds Targeting P2X7 | Discovery & Preclinical |  |
| AFC-5278 | Osteoporosis | Oral P2X7 Antagonist | Discovery | |
| AFC-08 | Depression | TMEFF2 Monoclonal Antibody | Discovery |  |
Copyright © 2012 Affectis Pharmaceuticals AG. All Rights Reserved.